Your browser is out of date

With an updated browser, you will have a better Medtronic website experience.

×

Skip to main content
This will play a video. - Inpact AV Access

THE IN.PACT™ ADMIRAL™
DRUG-COATED BALLOON FOR AV FISTULA

Be one of the first to see results from the global AV Access Clinical Trial
download the TRIAL RESULTS(opens new window)

new england journal of medicine

PUBLISHES LARGEST AV DCB PIVOTAL TRIAL*

 

56% FEWER INTERVENTIONS1MORE OF WHAT MATTERS

The IN.PACT™ AV ACCESS TRIAL demonstrated superiority of DCB vs PTA in increasing patency and prolonging time between interventions.1

VIEW PRODUCT DETAILS
#

PROACTIVE APPROACH

IN.PACT™ DCB treats the cause – not just the symptoms of fistula stenosis – enabling you to get ahead of restenosis and go longer between interventions.1

 

THE IN.PACT™
ADMIRAL™
DRUG-COATED BALLOON
FOR AV FISTULA

Contact Us

Request more information about IN.PACT™ ADMIRAL™ or any other product in our Peripheral portfolio.

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the .

You can always change your preferences or update your personal details by visiting the Preference center.

1Lookstein RA, et al. Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. N Engl J Med 2020;383:733-42. DOI: 10.1056/NEJMoa1914617. Highlighted results reported at both 180 and 210 days.

*In an AV DCB study.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at .

Not intended for US audience